169 related articles for article (PubMed ID: 26796267)
1. Long noncoding RNA LUNAR1 associates with cell proliferation and predicts a poor prognosis in diffuse large B-cell lymphoma.
Peng W; Feng J
Biomed Pharmacother; 2016 Feb; 77():65-71. PubMed ID: 26796267
[TBL] [Abstract][Full Text] [Related]
2. LincRNA-p21 predicts favorable clinical outcome and impairs tumorigenesis in diffuse large B cell lymphoma patients treated with R-CHOP chemotherapy.
Peng W; Wu J; Feng J
Clin Exp Med; 2017 Feb; 17(1):1-8. PubMed ID: 26475621
[TBL] [Abstract][Full Text] [Related]
3. Elevated RNA expression of long non‑coding HOTAIR promotes cell proliferation and predicts a poor prognosis in patients with diffuse large B cell lymphoma.
Yan Y; Han J; Li Z; Yang H; Sui Y; Wang M
Mol Med Rep; 2016 Jun; 13(6):5125-31. PubMed ID: 27122348
[TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNA HULC predicts poor clinical outcome and represents pro-oncogenic activity in diffuse large B-cell lymphoma.
Peng W; Wu J; Feng J
Biomed Pharmacother; 2016 Apr; 79():188-93. PubMed ID: 27044827
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of long noncoding RNA PEG10 associates with poor prognosis in diffuse large B cell lymphoma with facilitating tumorigenicity.
Peng W; Fan H; Wu G; Wu J; Feng J
Clin Exp Med; 2016 May; 16(2):177-82. PubMed ID: 25864113
[TBL] [Abstract][Full Text] [Related]
6. Aberrant NEAT1_1 expression may be a predictive marker of poor prognosis in diffuse large B cell lymphoma.
Deng L; Jiang L; Tseng KF; Liu Y; Zhang X; Dong R; Lu Z; Wang X
Cancer Biomark; 2018; 23(2):157-164. PubMed ID: 30175971
[TBL] [Abstract][Full Text] [Related]
7. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
[TBL] [Abstract][Full Text] [Related]
8. Reduced or absent cyclin H expression is an independent prognostic marker for poor outcome in diffuse large B-cell lymphoma.
Bavi P; Abubaker J; Hussain A; Sultana M; Al-Dayel F; Uddin S; Al-Kuraya KS
Hum Pathol; 2008 Jun; 39(6):885-94. PubMed ID: 18400256
[TBL] [Abstract][Full Text] [Related]
9. E2F1-induced upregulation of long noncoding RNA LINC00668 predicts a poor prognosis of gastric cancer and promotes cell proliferation through epigenetically silencing of CKIs.
Zhang E; Yin D; Han L; He X; Si X; Chen W; Xia R; Xu T; Gu D; De W; Guo R; Xu Z; Chen J
Oncotarget; 2016 Apr; 7(17):23212-26. PubMed ID: 27036039
[TBL] [Abstract][Full Text] [Related]
10. Decreased expression of lncRNA GAS5 predicts a poor prognosis in cervical cancer.
Cao S; Liu W; Li F; Zhao W; Qin C
Int J Clin Exp Pathol; 2014; 7(10):6776-83. PubMed ID: 25400758
[TBL] [Abstract][Full Text] [Related]
11. The Novel Notch-induced Long Noncoding RNA LUNAR1 Determines the Proliferation and Prognosis of Colorectal Cancer.
Zhang Z; Li G; Qiu H; Yang J; Bu X; Zhu S; Zheng J; Dang C; Wang W; Chu D
Sci Rep; 2019 Dec; 9(1):19915. PubMed ID: 31882986
[TBL] [Abstract][Full Text] [Related]
12. [Research on Ralation of Long Non-coding RNA with Diffuse Large B-cell Lymphomas -Review].
Wu YY; Xing YR; Yu DN
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Apr; 26(2):609-614. PubMed ID: 29665941
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and clinical implications of cyclin D1 expression in diffuse large B-cell lymphoma (DLBCL) treated with immunochemotherapy: a report from the International DLBCL Rituximab-CHOP Consortium Program.
Ok CY; Xu-Monette ZY; Tzankov A; O'Malley DP; Montes-Moreno S; Visco C; Møller MB; Dybkaer K; Orazi A; Zu Y; Bhagat G; Richards KL; Hsi ED; Han van Krieken J; Ponzoni M; Farnen JP; Piris MA; Winter JN; Medeiros LJ; Young KH
Cancer; 2014 Jun; 120(12):1818-29. PubMed ID: 24648050
[TBL] [Abstract][Full Text] [Related]
14. Predictive analysis of long non-coding RNA expression profiles in diffuse large B-cell lymphoma.
Zhu D; Fang C; Li X; Geng Y; Li R; Wu C; Jiang J; Wu C
Oncotarget; 2017 Apr; 8(14):23228-23236. PubMed ID: 28423571
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of the long non-coding RNA SPRY4-IT1 indicates a poor prognosis and promotes tumorigenesis in ovarian cancer.
Li H; Liu C; Lu Z; Chen L; Wang J; Li Y; Ma H
Biomed Pharmacother; 2017 Apr; 88():529-534. PubMed ID: 28129625
[TBL] [Abstract][Full Text] [Related]
16. [Expression of dendritic cell marker CD21 is a positive prognostic factor in diffuse large B-cell lymphoma].
Yao WK; Wang YP; Peng F; Zheng Y; Zou YB; Gao JN; Liu XL
Zhonghua Bing Li Xue Za Zhi; 2012 Dec; 41(12):818-22. PubMed ID: 23324230
[TBL] [Abstract][Full Text] [Related]
17. Increased MALAT1 expression predicts poor prognosis in primary gastrointestinal diffuse large B-cell lymphoma.
Qian Z; Chen L; Wang X; Kan Y; Wang Y; Yu Y; Wang X; Zhao Z; Yang H; Ge P; Ding T; Zhai Q; Zhao H
Clin Exp Med; 2022 May; 22(2):183-191. PubMed ID: 34427833
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA PANDAR correlates with poor prognosis and promotes tumorigenesis in hepatocellular carcinoma.
Peng W; Fan H
Biomed Pharmacother; 2015 May; 72():113-8. PubMed ID: 26054684
[TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA HULC is a novel biomarker of poor prognosis in patients with pancreatic cancer.
Peng W; Gao W; Feng J
Med Oncol; 2014 Dec; 31(12):346. PubMed ID: 25412939
[TBL] [Abstract][Full Text] [Related]
20. LncRNA-LUNAR1 Levels Are Closely Related to Coronary Collaterals in Patients with Chronic Total Coronary Occlusion.
Lu W; Sheng Z; Zhang Z; Ma G; Chen L; Huang J; Ding J; Dai Q
J Cardiovasc Transl Res; 2020 Apr; 13(2):171-180. PubMed ID: 31997261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
